According to Fortune Business Insights, the global lab-grown food market was worth roughly $410.5 million in 2025. The firm expects the market to climb to about $580.5 million in 2026 and then expand sharply to nearly $12 billion by 2034, implying a compound annual growth rate of close to 46% across the 2026–2034 forecast window. Lab-grown food — also called cultivated or cell-based food — refers to products made by growing animal cells in a controlled setting rather than raising and slaughtering livestock. The category spans cultured meat and seafood produced through cellular agriculture and related biotech processes.
Asia Pacific was the largest regional market in 2025, holding roughly 48% of global revenue, ahead of North America and Europe. Leading companies named in the report include Upside Foods, Mosa Meat, and Aleph Farms, alongside firms such as Eat Just, GOOD Meat, Believer Meats, Meatable, Vow, BlueNalu, SuperMeat, and Wildtype.
Growth Drivers
The report points to mounting strain on conventional protein production — a growing global population, shrinking arable land and water resources, and the environmental footprint of livestock farming (including greenhouse gas output) — as central forces pushing investment toward cellular agriculture. Animal-welfare and ethical-eating concerns are pulling some consumers toward cultivated alternatives, while venture capital and government-backed innovation programs continue to fund the technology's development. Early regulatory clearances, notably in Singapore and the United States, have let a handful of companies begin limited commercial sales, which the report frames as an important proof point for the wider industry.
Get a Free Sample PDF - https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/lab-grown-food-market-117014
Restraints and Challenges
Despite the growth outlook, the report flags several headwinds. Production costs remain high, particularly for cell-culture media and bioreactor equipment, and scaling manufacturing beyond pilot volumes is difficult and capital-intensive. Regulatory approval is still unavailable or slow-moving in many countries, limiting where products can legally be sold. Consumer awareness and comfort with "lab-grown" food is also uneven, and cultivated products face competition from an already more established plant-based meat sector.
Opportunities
Fortune Business Insights sees room for progress through cheaper growth media, more efficient bioprocessing, and greater automation, all of which could narrow the cost gap with conventional meat. Hybrid products that blend cultivated cells with plant-based ingredients are highlighted as a practical way to cut costs while still offering a novel product. Partnerships with foodservice operators, ingredient suppliers, and research institutions are described as a faster route to market than pursuing large-scale standalone production, and export-oriented strategies aimed at food-insecure regions are cited as an additional growth avenue.
Market Segmentation
By format, whole-cut or structured products led the market in 2025 because they most closely mimic the texture and eating experience of conventional meat, giving companies a premium positioning tool. Blended or hybrid products are expected to be the fastest-growing format, at roughly a 47% CAGR, since combining cultivated cells with plant-based ingredients helps control cost.
By product type, cultivated poultry held the largest share in 2025, helped by the fact that avian cells reproduce faster than other animal cells, shortening bioreactor cycles. Cultivated pork fat and fat-enabled products ranked second, since fat cells are simpler and cheaper to produce than whole-muscle cuts and can also be blended into other products.
By end use, R&D, regulatory, and pilot facilities accounted for the largest share in 2025, reflecting how much of the industry is still in a development and approval-seeking phase. Commercial food sales is projected to be the fastest-growing end-use segment, at close to a 47% CAGR, as restaurants and foodservice venues offer a controlled setting for companies to introduce products at premium prices while gathering consumer feedback.
Regional Highlights
Asia Pacific led in 2025 at about $199 million, powered by Singapore's status as the first country to approve commercial sale of cultivated meat, along with heavy Chinese and Japanese investment tied to food-security goals. North America followed at roughly $110 million, with the U.S. market (about $101 million) benefiting from FDA and USDA approvals for companies such as Upside Foods and GOOD Meat. Europe trailed at about $67 million, held back by a more cautious, fragmented regulatory process under EFSA. South America and the Middle East & Africa remain the smallest regions, with limited startup activity and infrastructure so far.
Competitive Landscape
The report describes a market led by a relatively small group of well-funded companies competing primarily on production scale-up, bioreactor efficiency, and cost per kilogram rather than branding. Recent milestones cited include Mission Barns' first commercial sale of cultivated pork in September 2025 and Wildtype's restaurant launch of cultivated salmon in June 2025.